Sixteen countries authorised the use of Russia's Sputnik V vaccine before phase 3 clinical trial results were published.
COVID-19 vaccine passports are being presented as a relatively simple technological solution to our current travel woes. But meaningful public debate about their merits and problems is essential.
A divide is growing between workers and management over the return to the office and other issues.
Offering incentives to encourage good health behavior isn't new, but it does raise concerns. A behavioral scientist explains how rewarding those taking a shot need not keep ethicists up at night.
What does the Seychelles experience tell us about variants, vaccine efficacy and herd immunity?
While the pandemic has focused the world’s attention on how to prevent infectious disease, many of the lessons learned from COVID-19 prevention can also be applied to chronic disease prevention.
Teens have acutely felt the effects of the pandemic lockdowns on their social lives. As the end of stay-at-home orders draws nearer, it's important to consider teenagers' social and emotional needs.
The pandemic's not over yet, but these world leaders have already cemented their place in history for failing to effectively combat the deadly coronavirus. Some of them didn't even really try.
A public health expert outlines what Britons can expect from their upcoming booster programme.
It's feasible to bring home at least some of the COVID-positive Australians stranded in India. Here's how we can do it while keeping infection risk at a minimum.
While the results are very promising, it has only been tested in mice. Human clinical trials will take some time to complete before we know whether a drug could become available.
The United States and Canada have approved the Pfizer vaccine for adolescents aged 12–15. The evidence so far tells us it works well and is safe for this age group.
The mental health crisis occurring in tandem with COVID-19 has stressed resources and stretched service waitlists into years. There is an urgent need for prevention strategies, not just treatment.
Governments and companies are using incentives in hopes of getting more Americans to get a COVID-19 shot. A behavioral economist explains how they work.
Research has shown that vaccines have reduced infections, disease and hospitalisations – but will they continue to do so in the face of new variants?
Reports of fully vaccinated people getting infected with coronavirus shouldn't cause alarm.
National procedures for approving the financing of the European recovery plan are delaying its implementation. But the horizon seems to be clearing.
As the Indian variant becomes more prevalent within our borders, anti-South Asian sentiment is also growing, putting the community at a higher risk of hate crimes.
Vaccination rates for COVID-19 have been lower than desired for herd immunity, or when enough people become immune for new infections to stop. What will life look like without it?
The Pfizer COVID-19 vaccine was recently approved for adolescents ages 12-15. Vaccination is essential to protect children from serious illness and quicken return to normal life.